US Bancorp’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $130K | Buy |
2,749
+541
| +25% | +$25.5K | ﹤0.01% | 2300 |
|
|
2025
Q1 | $86.3K | Buy |
2,208
+1,178
| +114% | +$46K | ﹤0.01% | 2453 |
|
|
2024
Q4 | $55.8K | Buy |
1,030
+161
| +19% | +$8.72K | ﹤0.01% | 2679 |
|
|
2024
Q3 | $43.8K | Buy |
+869
| New | +$43.8K | ﹤0.01% | 2796 |
|
|
2023
Q4 | – | Sell |
-3,547
| Closed | -$202K | – | 4051 |
|
|
2023
Q3 | $202K | Buy |
+3,547
| New | +$202K | ﹤0.01% | 1822 |
|